Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka 565-0871, Japan.
Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, Kita 2 jou Nishi 5, Kitaku, Sapporo, Hokkaido 060-8638, Japan.
J Infect Chemother. 2014 Mar;20(3):157-62. doi: 10.1016/j.jiac.2013.07.006. Epub 2013 Dec 11.
Severe sepsis is a leading cause of morbidity and mortality in the intensive care unit (ICU). We conducted a prospective multicenter study to evaluate epidemiology and outcome of severe sepsis in Japanese ICUs. The patients were registered at 15 general critical care centers in Japanese tertiary care hospitals when diagnosed as having severe sepsis. Of 14,417 patients, 624 (4.3%) were diagnosed with severe sepsis. Demographic and clinical characteristics at enrollment (Day 1), physiologic and blood variables on Days 1 and 4, and mortality were evaluated. Mean age was 69.0 years, and initial mean Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores were 23.4 and 8.6, respectively. The 28-day mortality was 23.1%, and overall hospital mortality was 29.5%. SOFA score and disseminated intravascular coagulation (DIC) score were consistently higher in nonsurvivors than survivors on Days 1 and 4. SOFA score, DIC score on Days 1 and 4, and hospital mortality were higher in patients with than without septic shock. SOFA score on Days 1 and 4 and hospital mortality were higher in patients with than without DIC. Logistic regression analyses showed age, presence of septic shock, DIC, and cardiovascular dysfunction at enrollment to be predictors of 28-day mortality and presence of comorbidity to be an additional predictor of hospital mortality. Presence of septic shock or DIC resulted in approximately twice the mortality of patients without each factor, whereas the presence of comorbidity may be a significant predictor of delayed mortality in severe sepsis.
严重脓毒症是重症监护病房(ICU)发病率和死亡率的主要原因。我们进行了一项前瞻性多中心研究,以评估日本 ICU 中严重脓毒症的流行病学和结局。当患者被诊断为患有严重脓毒症时,将在日本三级保健医院的 15 个普通重症监护中心登记。在 14417 名患者中,有 624 名(4.3%)被诊断为严重脓毒症。评估了入组时(第 1 天)的人口统计学和临床特征、第 1 天和第 4 天的生理和血液变量以及死亡率。平均年龄为 69.0 岁,初始平均急性生理学和慢性健康评估(APACHE)Ⅱ和序贯器官衰竭评估(SOFA)评分分别为 23.4 和 8.6。28 天死亡率为 23.1%,总住院死亡率为 29.5%。第 1 天和第 4 天,存活者与非存活者的 SOFA 评分和弥散性血管内凝血(DIC)评分始终较高。有或没有脓毒性休克的患者中,SOFA 评分、第 1 天和第 4 天的 DIC 评分以及住院死亡率均较高。第 1 天和第 4 天的 SOFA 评分和住院死亡率在有 DIC 的患者中高于无 DIC 的患者。Logistic 回归分析显示,年龄、存在脓毒性休克、DIC 和入组时的心血管功能障碍是 28 天死亡率的预测因素,并存疾病是住院死亡率的另一个预测因素。存在脓毒性休克或 DIC 的患者的死亡率约为无这些因素的患者的两倍,而并存疾病可能是严重脓毒症延迟死亡的一个重要预测因素。